Cargando…

Internet-delivered cognitive-behavioral therapy for insomnia and comorbid symptoms

BACKGROUND: Cognitive-behavioral therapy for insomnia (CBTi) is considered the standard treatment. The internet has proven to be a useful and successful tool of providing CBTi. However, few studies have investigated the possible effect of unguided internet-delivered CBTi (ICBTi) on comorbid psycholo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagatun, Susanne, Vedaa, Øystein, Harvey, Allison G., Nordgreen, Tine, Smith, Otto R.F., Pallesen, Ståle, Havik, Odd E., Thorndike, Frances P., Ritterband, Lee M., Sivertsen, Børge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096334/
https://www.ncbi.nlm.nih.gov/pubmed/30135764
http://dx.doi.org/10.1016/j.invent.2018.02.003
Descripción
Sumario:BACKGROUND: Cognitive-behavioral therapy for insomnia (CBTi) is considered the standard treatment. The internet has proven to be a useful and successful tool of providing CBTi. However, few studies have investigated the possible effect of unguided internet-delivered CBTi (ICBTi) on comorbid psychological symptoms and fatigue. METHODS: Based on a randomized controlled trial, we investigated whether unguided ICBTi had an effect on comorbid psychological symptoms. Adults with insomnia (n = 181; 67% women; mean age 44.9 years [SD 13.0]) were randomized to ICBTi (n = 95) or to an online patient education condition (n = 86) for a nine-week period. RESULTS: The results from mixed linear modelling yielded medium to large between-group effect sizes from pre- to post-treatment for symptoms of anxiety or depression (d = −0.57; 95% CI = 0.79–0.35) and fatigue (d = 0.92; 95% CI = 1.22–0.62). The ICBTi group was reassessed at a 6-month non-randomized follow-up, and the completing participants had on the average a significant increase (from the post-assessment) on symptoms of anxiety or depression, while the reduction in symptoms of fatigue (on post-assessment) was maintained. However, due to high dropout attrition and no control group data, caution should be made regarding the long-term effects. In conclusion, the present findings show that unguided ICBTi positively influence comorbid symptoms in the short-term, thereby emphasizing the clinical relevance of unguided ICBTi. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02261272